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1 This study examined the effect of interleukin-1ß (IL-Iß) on the capsaicin-induced increase in 
cutaneous blood fiow of anaesthetized rats as measured by laser Doppler fiowrnetry. 
2 The substances were adrninistered by intraplantar subcutaneous injection of 10 Ill-volumes, saline 
being injected into one hindpaw and IL-Iß into the other. 
3 IL-Iß (0.5-500 pg) was without effect on blood fiow on its own but dose-dependently enhanced the 
hyperaemic response to intraplantar capsaicin (O.3llg) up to 180% (P< 0.05) of the response seen in 
saline-treated paws. 
4 Il-Iß-(l63-171), a fragment devoid of proinfiammatory activity, failed to enhance capsaicin-induced 
hyperaemia when given at a dose of 50 pg. 
5 Indomethacin (IOmgkg- 1, i.p.) did not alter the capsaicin-induced vasodilatation but prevented 
IL-Iß (50 pg) from augmenting the hyperaemic response to capsaicin. 
6 The hyperaemia evoked by intraplantar ca1citonin gene-related peptide (0.038-3.8 ng) was not 
altered by IL-Iß (50 pg). 
7 These data indicate that IL-Iß enhances the cutaneous hyperaemic response to afferent nerve 
stimulation with capsaicin in a prostaglandin-dependent manner. This proinfiammatory action of the 
cytokine appears to arise from sensitization of afferent nerve endings. 
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of afferent nerve endings; proinfiammatory action; prostaglandins; ca1citonin gene-related peptide (CGRP) 
Introduction 
Intradermal injection of capsaicin leads to vasodilatation and 
increased vascular permeability (Hughes & Brain, 1991). 
These effects are elicited by activation of nociceptive afferent 
nerve fibres and release of vasoactive peptides from their 
peripheral endings. Among them, ca1citonin gene-related pep-
tide (CGRP) and substance P are the best studied candidate 
mediators (Holzer, 1992). The process of neurogenic 
infiammation is pathophysiologically relevant because it is 
potentially involved in a variety of diseases including 
infiammation of the skin, eye and respiratory tract, arthritis, 
migraine, and infiammatory bowel disease (Holzer, 1988; 
Maggi & Meli, 1988; Barnes, 1991; Basbaum & Levine, 1991; 
Moskowitz & Buzzi, 1991; Sharkey, 1992). 
In addition to altering vascular functions, peptides re1eased 
from afferent nerve endings can infiuence the activity of 
immunocompetent cells including mast cells, granulocytes, 
macrophages and lymphocytes (Donnerer et al., 1990; 
McGillis et al., 1990; Holzer, 1992). Mediators released from 
these cells, such as histamine and prostaglandins, can sen-
sitize afferent nerve endings and in this way lead to 
hyperalgesia and prolong the infiammatory process (Hand-
werker, 1991). Sensitization is expected to facilitate the 
release of neuropeptides from afferent nerve endings and thus 
to reinforce the signs of neurogenic infiammation. Another 
putative link between the immune system and afferent nerve 
fibres is interieukin-1ß (IL-Iß). This cytokine is not only a 
major immune mediator but is also able to initiate 
infiammatory reactions or to exacerbate existing 
infiammation (Dinarello, 1992). 
The present study was designed to examine the effect of 
IL-Iß on neurogenic infiammation as measured by the 
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cutaneous vasodilator response to the afferent nerve 
stimulant, capsaicin, in the rat hindpaw. As IL-Iß was found 
to enhance the vasodilator action of capsaicin, further 
experiments were aimed at e1ucidating the mechanism of the 
sensitizing effect of this cytokine. 
Methods 
Animal preparation 
The experiments of this study were approved by the Austrian 
Ministry of Science and Research. Female Sprague-Dawley 
rats (Versuchstierzuchtanstalt Himberg, Austria) weighing 
180-245 g were anaesthetized with phenobarbitone, 250 mg 
kg- 1 i.p. (Lippe & Holzer, 1992). Additional doses of 
phenobarbitone (25-50mgkg- 1) were given as required to 
achieve a deep level of anaesthesia, which was checked by the 
absence of any reaction to pinching the forepaw in the 
interdigital web with a surgical clamp. In all animals the 
trachea was cannulated and blood pressure was monitored 
continuously via a catheter in the right carotid artery. Rectal 
temperature was monitored and maintained at a 
physiological level of 37.5 to 38°C with the aid of a heating 
pad. 
A transparent probe holder for laser Doppler fiowmetry 
(see below) was fixed rigidly with double-sided adhesive tape 
to the plantar skin of each paw. Then the probe holders were 
mounted to a frame keeping the paws in a vertical position. 
To ensure optimal paw perfusion, the rats were positioned 
supine and with their rostro-caudal axis inclined such that 
the level of the hindpaws was identical with that of the heart. 
The experimental procedure started after a 1 h resting period 
for stabilization of blood pressue, body temperature and 
plantar skin blood fiow. 
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Measurement of cutaneous bloodjlow 
Cutaneous blood flow was measured with a laser Doppler 
flowmeter (Periflux PF3, Perimed, Sweden) which operates 
on the principle that a virtually monochromatic laser beam 
(2 mW helium-neon laser) scattered by moving red blood 
cells undergoes a frequency shift according to the Doppler 
effect, while light scattered in static tissues remains unshifted 
in frequency. The laser light is guided to the skin surface by 
an optical fibre and permeates the skin up to a depth of 
I mm. Part of the reflected light is collected and transmitted 
by 2 optical fibres to 2 photodetectors. The output signal of 
the Periflux PF3 is expressed in dimensionless blood flow 
values (perfusion units, PU) and represents the red blood cell 
flow (determined by the number and velocity of these cells) in 
a semisphere with a radius of about 1 mm (Oberg et al., 
1984). 
For the determination of the PU zero level, the laser probe 
was placed on a white static surface and the value of 250 PU 
was calibrated against the physical motility standard solution 
PFlOO (Perimed) under the conditions recommended by 
Perimed. The band width of the instrument was set at 12 kHz 
and the time constant of the damping filter was set at 3 s in 
order to smooth out fluctuations due to the cardiac cycle. 
For measurement of skin blood flow, the laser probe was 
inserted into the probe holder attached to the plantar skin 
and thus applied perpendicularly to the skin surface. After a 
20-30 s period of stabilization, skin blood flow was deter-
mined as the average PU recorded during aperiod of 
15-20 s. 
Subcutaneous injection protocol 
Intraplantar subcutaneous injections of 10 /LI volumes were 
performed with a 50/LI Hamilton syringe and a 27 gauge 
needle (0.4 x 12 mm) which was inserted from the lateral 
aspect of the hindpaw. The tip of the needle was directed 
subcutaneously into the centre of the hole of the laser probe 
holder. With the tip of the needle in this position, the 10 /LI 
volume was injected carefully under direct view. This small 
injection volume had the advantage of being readily absorbed 
by the tissue within a few minutes, as judged by the disap-
pearance of the local blanching seen immediately after the 
injection. 
The injection protocol was identical in all experiments 
inasmuch as the first injection was given into the right paw, 
while the second injection was given into the left paw after 
an interval of 45-60 s. This interval provided enough time to 
record the cutaneous blood flow in the right paw and then to 
place the laser probe on the left paw. 
Experimental groups 
All experimental groups consisted of 6 rats: treatment was as 
folIows: 
Groups 1-4 Doses of 0.5-500 pg IL-Iß, dissolved in sterile 
saline, were injected into the left paw. The right paws served 
as controls and received an equal volume (10 /LI) of saline. 
Forty min later 0.3 /Lg/IO /LI capsaicin was injected into those 
areas of both paws which had been pretreated with IL-Iß or 
saline (see Figure I). The dose of 0.3 /Lg capsaicin was chosen 
after preliminary experiments had shown this dose to be 
suprathreshold in causing a reproducible increase in skin 
blood flow. Since desensitization to capsaicin is a characteris-
tic consequence of topical application of the drug to the rat 
skin (Lynn et al., 1992), capsaicin was administered only 
once to each paw. 
Group 5 Rats were pretreated by injection of 50 pg IL-Iß 
into both hindpaws. After 40 min 0.3 /Lg/1O /LI capsaicin was 
injected into the left hindpaw while the right hindpaw 
received 10 /LI saline. 
Group 6 A dose of 50 pg ofIL-Iß-(163-171), a fragment of 
human IL-Iß devoid of inflammatory activity (Antoni et al., 
1986), was injected into the left hindpaw, the contralateral 
paw receiving saline alone. Forty min later 0.3 /Lg/I0 /LI cap-
saicin was injected into both hindpaws (see Figure 2). 
Groups 7-10 To examine the possible involvement of 
prostaglandins in the sensitizing effect of IL-Iß, rats were 
pretreated with indomethacin (10 mg kg- I body weight) or its 
vehicle (I ml kg- I), which were injected intraperitoneally 
60 min prior to the subcutaneous injection of 50 pg IL-Iß or 
saline. Forty min later 0.3 /Lg/1O /LI capsaicin was injected 
into both paws (see Figure 3). 
Groups 11-13 To study the effect ofIL-Iß on the cutaneous 
vasodilatation induced by calcitonin gene-re1ated peptide 
(CGRP) this peptide (0.038, 0.38 and 3.8 ng in 10 /LI saline) 
was injected into both hindpaws 40 min after IL-Iß (50 pg) 
had been injected into the left paw and saline (10 /LI) into the 
right paw (see Figure 4). 
Group 14 In a separate experiment the change in the paw 
volume after intraplantar injection of saline (50/LI) into the 
right hindpaw and of capsaicin (1.5 /Lg in 50/LI saline) into 
the left hindpaw was examined with a plethysmometer 
(model 7150, Ugo Basile, Comerio-Varese, Italy). The paw 
volume was measured 5, 20 and 35 min post-injection. 
Recording protocol 
Cutaneous blood flow was measured three times at 15 min 
intervals before the first injection. In this way control record-
ings were made on each paw at - 35, - 20 and - 5 min. At 
time 0 the first injection (usually IL-Iß or saline) was per-
formed. A second series of recordings was made 5, 20 and 
35 min after this injection. Forty min after the first injection, 
the second injection (usually capsaicin or CGRP) was carried 
out. The interval of 40 min was chosen because the effect of 
IL-Iß in sensitizing nociceptors is fully developed within 1 h 
(Ferreira et al., 1988) and because the time of the experiment 
was to be kept short as skin blood flow tended to fall slightly 
with time (Figure I). The third series of recordings started 
5 min after the second injection, i.e. 45 min after the first 
injection, and was continued at 60 and 75 min. 
Statistics 
The results are expressed as means ± s.e.mean. For statistical 
evaluation the PU values of the right and left paw, recorded 
5 min after the capsaicin injection, were analysed with the 
Wilcoxon matched-pairs signed rank test (two-tailed). This 
test was also used to compare peak changes of blood flow 
induced by saline with those induced evoked by IL-Iß or 
capsaicin. A value of P<0.05 was regarded as significant. 
Substances 
Human recombinant IL-Iß and IL-Iß-fragment-{l63-171) 
were purchased from Sigma (Deisenhofen, Germany), cal-
citonin gene-related peptide (rat CGRP-ot) from Bachern 
(Bubendorf, Switzerland), capsaicin from Fiuka (Buchs, 
Switzerland), and indomethacin from Merck, Sharp and 
Dohme (Munich, Germany). All other chemicals were from 
commercial sources and were of analytical purity. Capsaicin 
was dissolved in absolute ethanol and dissolved with saline 
such that the ethanol concentration in the injection solution 
was 0.1 % (weight/weight). Indomethacin was dissolved in 
2% (wt/wt) Na2C03 at a concentration of 30 mg mi-I and 
further diluted with saline to a concentration of 10 mg mi-I. 
CGRP was dissolved (100/LM) in, and diluted with, saline. 
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Results 
General observations 
Cutaneous blood flow during the control period ( - 35, - 20, 
- 5 min) was similar in both paws of all groups and tended 
to fall slightly during the time of the experiment (Figure I). 
The injection of 10 /-LI saline increased blood flow from 
56.8 ± 6.5 to 79.5 ± 8.5 PU (n = 6) as measured 5 min post-
injection while injection of 50 pg IL-Iß enhanced skin blood 
flow from 59.3 ± 9.1 to 91.8 ± 12.2 PU (n = 6). The effect of 
IL-Iß was not significantly different from that caused by 
saline and was not related to the dose of IL-Iß injected (not 
shown). Twenty and 35 min post-injection skin blood flow 
had always returned to the level measured before the first 
injection. 
Subcutaneous injection of 0.3/-Lg capsaicin into the saline-
treated paw augmented plantar blood flow by 144.1 ± 61.0% 
(n = 6) (Figure I), this increase being significantly (P<0.05) 
higher than that caused by saline alone (26.7 ± 21.0%, 
n = 6). In the paw treated with 50 pg IL-Iß, capsaicin 
enhanced blood flow by 223.0 ± 56.8% (n = 6). This 
hyperaemic reaction to capsaicin was significantly larger than 
that seen in the saline-treated paw (Figure I). Blood flow 
returned to basal values within 20 min from the injection of 
capsaicin into the saline-treated paw, whereas blood flow in 
the paw treated with IL-Iß took longer to return to the 
pre-capsaicin level (Figure I). 
In a control experiment both paws were pretreated with 
50 pg IL-Iß. Injection of 0.3/-Lg/IO /-LI capsaicin into the left 
paw increased cutaneous blood flow from 38.2 ± 7.8 PU to 
106.8 ± 21.0 PU (n = 6). The effect of capsaicin was 
significantly (P< 0.05) higher than the minor effect of saline 
which after injection into the right paw increased blood flow 
from 36.8 ± 6.8 PU to 52.5 ± 10.2 PU (n = 6). This observa-
tion corroborates that the vasodilator reaction to capsaicin 
represents primarily areaction to this algesie chemical and 
not areaction to the needle insertion or injection of a 10 /-LI 
volume of fluid. 
In another experiment it was observed that, at the doses 
used here, capsaicin failed to augment vascular permeability 
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Figure 1 Time course of the effect of interleukin-Iß in enhancing the 
cutaneous hyperaemia evoked by capsaicin (Caps). At time 0, saline 
(10/-11) was injected into the plantar side of the right paw whilst the 
left paw was treated with 50 pg interleukin-Iß. Forty min later 
capsaicin (Caps, 0.3 /-Ig) was injected into each paw. Cutaneous 
blood ftow in the right saline-treated (hatched columns) and left 
IL-Iß-treated (solid columns) hindpaw was recorded by laser Dopp-
ler ftowrnetry and expressed in perfusion units (PU). Results are 
mean with s.e.mean; n = 6. * P < 0.05 versus respective values 
measured in the saline-treated paw (two-tailed Wilcoxon matched-
pairs signed rank test). 
in the rat hindpaw as determined by plethysmometry. The 
maximal rise of the paw volume as seen 5 to 20 min after 
intraplantar injection of 1.5/-Lg capsaicin in 50111 saline 
amounted to 14 ± 3% (n = 6), which did not differ from the 
rise evoked by 50111 saline alone (13 ± 2%, n = 6). 
Effect of IL-Iß on capsaicin-induced hyperaemia 
The effect of intraplantar IL-Iß in enhancing the capsaicin-
induced increase in cutaneous blood flow, for the sake of 
brevity referred to as 'sensitizing effect' , depended on the 
dose of the cytokine (Figure 2). Doses as low as 0.5 pg IL-Iß 
(Figure 2) tended to increase the capsaicin-evoked 
vasodilator effect but the response to this dose of the 
cytokine did not reach statistical significance. With 5 pg IL-
Iß, however, the capsaicin-induced cutaneous hyperaemia 
was significantly enhanced (Figure 2). A further increase in 
the dose of IL-Iß to 50 pg did not further enhance the 
magnitude of the sensitizing effect (Figure 2) but caused a 
longer-lasting augmentation of the capsaicin-evoked 
hyperaemia than the dose of 5 pg IL-Iß (not shown). 
Pretreatment of the hindpaw with 500 pg IL-Iß also tended 
to enhance the hyperaemic response to capsaicin but the 
sensitizing effect of this cytokine dose did not reach statistical 
significance (Figure 2). It remains to be determined whether 
the failure of the highest dose ofIL-Iß was due to absorption 
of the cytokine into the circulation and augmentation of the 
capsaicin-induced hyperaemia in the contralateral paw. Mean 
arterial blood pressure was not affected by this dose of the 
cytokine (n = 6). 
Effect of IL-Iß-(163-171) on capsaicin-induced 
hyperaemia 
The fragment IL-Iß-(163-171) injected at a dose of 50pg 
failed to exert any sensitizing effect on capsaicin-induced 
cutaneous vasodilatation. Five min post-injection the 
hyperaemic responses to capsaicin were identical in the IL-
Iß-(163-171)-treated and saline-treated paws (Figure 2), and 
this was also true for the recordings taken 60 and 75 min 
post-injection. 
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Figure 2 Dose-response relationship for the interleukin-Iß (IL-Iß)-
induced enhancement of the cutaneous hyperaemia evoked by cap-
saicin and the lack of effect of the fragment IL-Iß-(l63-171) (ILF). 
Saline (10/-11) was injected into the plantar side of the right paw 
(hatched columns) whilst the left paw (solid columns) was treated 
with IL-Iß or ILF. Forty min later capsaicin (0.3/-1g) was injected 
into each paw. Cutaneous blood ftow was recorded by laser Doppler 
ftowmetry and expressed in perfusion units (PU). Results are mean 
with s.e.mean; n = 6. * P < 0.05 versus respective values measured in 
the saline-treated paw (two-tailed Wilcoxon matched-pairs signed 
rank test). 
684 M.K. HERBERT & P. HOLZER 
E.fJects 0/ indomethacin 
Neither basal blood flow in the hindpaw nor the vasodilator 
response to capsaicin was aItered by intraperitoneal injection 
of indomethacin (10 mg kg- 1) when compared with the 
respective blood flow values measured after intraperitoneal 
injection of vehicIe (Figure 3a). These experiments also 
showed that in both vehicIe- and indomethacin-pretreated 
rats the hyperaemic reaction to intraplantar capsaicin in the 
left hindpaw was identical with that in the right paw when 
saline had been injected into either paw 40 min before cap-
saicin (Figure 3a). The injection of 50 pg/1O 1'1 IL-Iß to the 
left hindpaw of vehicle pretreated rats enhanced the 
vasodilator effect of capsaicin (Figure 3b) to an extent which 
was similar to that seen in untreated rats (Figures 1 and 2). 
This sensitizing effect of IL-Iß was absent in rats treated with 
indomethacin (Figure 3b). 
E.fJect 0/ IL-1ß on CGRP-induced hyperaemia 
Intraplantar injection of CGRP (0.038-3.8 ng) caused a 
dose-dependent increase in cutaneous blood flow (Figure 4). 
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Figure 3 Effect of intra plantar capsaicin on cutaneous blood fiow in 
rats pretreated with indomethacin or its vehicle. Indomethacin 
(10 mg kg- 1) or its vehicle was administered intraperitoneally 60 min 
before saline or interleukin-Iß was injected into the plantar side of 
the hindpaw. In (a) saline (10/011) was given to either paw whereas in 
(b) saline (10/011) was injected into the right paw and interleukin-Iß 
(50 pg) into the left paw. Forty min later capsaicin (Caps, 0.3 /oIg) 
was injected into each paw. Cutaneous blood fiow in the right 
(hatched columns) and left (solid columns) hindpaw was recorded by 
laser Doppler fiowrnetry and expressed in perfusion units (PU). 
Results are mean with s.e.mean; n = 6. • P < 0.05 versus respective 
values measured in the saline-treated paw (two-tailed Wilcoxon 
matched-pairs signed rank test). 
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Figure 4 Effect of interleukin-Iß on the cutaneous hyperaemia 
evoked by calcitonin gene-related peptide (CGRP). Saline (10/011) was 
injected into the plantar side of the right hindpaw (hatched columns) 
whilst the left paw (solid columns) was treated with interieukin-Iß 
(50 pg). Forty min later CGRP (doses as indicated) was injected into 
each paw. Cutaneous blood fiow was recorded by laser Doppler 
fiowrnetry and expressed in perfusion units (PU). Results are mean 
with s.e.mean; n = 6. 
The magnitude of the CGRP-evoked hyperaemia was the 
same when saline (101'1) or IL-Iß (50 pg) had been injected 
into the hindpaw 40 min before the administration of CGRP 
(Figure 4). 
E.fJects on blood pressure 
At the time of the first injection into the hindpaws mean 
arterial blood pressure was 104 ± 3 mmHg (n = 78). During 
the time of the experiment, blood press ure decreased on 
average by 10-20 mmHg. Rats were excIuded from the study 
if blood pressure dropped below 80 mmHg during the experi-
ment. In most of the rats, blood pressure rose transiently 
during/after insertion of the needle into the subcutaneous 
space of the hindpaw and the intraplantar injection of sub-
stances. Whilst pressor responses to intraplantar injection of 
saline or IL-Iß did not differ from each other, the pressor 
responses to intraplantar capsaicin (0.3I'g/1O 1'1) were con-
sistently higher than those to saline or IL-Iß. The increase in 
blood pressure following capsaicin injection was about 
20 mmHg and las ted usually less than 4 min. 
Discussion 
The major finding of the present study was the discovery that 
IL-Iß enhanced the cutaneous vasodilator action of cap-
saicin. The sensitizing effect of IL-Iß depended on the dose 
injected and was seen with picogram amounts of the 
cytokine. This high potency of IL-Iß in augmenting 
capsaicin-evoked hyperaemia is comparable with the high 
activity of the cytokine in sensitizing the rat hindpaw to 
noxious pressure stimuli (Ferreira et al., 1988; FolIenfant et 
al., 1989). The vasodilator action of capsaicin in the skin is 
due to stimulation of afferent nerve endings and subsequent 
release of vasodiIator transmitters (Holzer, 1992), among 
which CGRP plays a major role, at least in the rabbit skin 
(Hughes & Brain, 1991). Since IL-Iß failed to enhance the 
vasodilator response to CGRP it is inferred that this cytokine 
augmented the hyperaemic response to capsaicin by a sen-
sitizing action on afferent nerve fibres but did not alter the 
sensitivity of blood vessels to the released vasodilator pep-
tide. Together with the findings on nociception (Ferreira et 
al., 1988; FolIenfant et al., 1989) the present data indicate 
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that IL-Iß can sensitize afferent nerve fibres to both chemical 
and mechanical noxious stimuli, which results, on the one 
hand, in enhanced release of vasodilator transmitters from 
the peripheral nerve endings and, on the other hand, in 
hyperalgesia. 
IL-Iß is released from activated macrophages and a large 
variety of other cell types inc1uding B-Iymphocytes and 
endothelial cells (Libby et al., 1986; Howells et al., 1988; 
Dinarello, 1991) and is considered to be a key mediator of 
the immune and intlammatory reactions to infectious and 
foreign agents (Dinarello, 1992). This cytokine is not only a 
prointlammatory substance (Stimpson et al., 1988; Horn et 
al., 1992; van de Loo et al., 1992) but can per se induce 
intlammation and tissue destruction (Pettipher et al., 1986; 
Chandrasekhar et al., 1990). The finding that intra-articular 
injection of IL-l induces release of substance P, presumably 
from afferent nerve fibres, into the synovial tluid (O'Byrne et 
al., 1990a,b) suggests that cytokines themselves could evoke 
signs of neurogenic intlammation. The present study, though, 
failed to furnish conc1usive evidence for IL-Iß-induced 
intlammatory reactions in the rat hindpaw skin. 
The ability of IL-Iß to augment the neurogenic vasodilator 
response to capsaicin needs to be seen in context with its 
ability to intluence the activity and function of various 
immune and connective tissue cells (O'Byrne et al., 1991; 
Dinarello, 1992). Specifically, IL-Iß stimulates Iymphocytes 
to release other cytokines (Lowenthal et al., 1986) and causes 
fibroblasts and synovial cells to produce prostagiandin E2 
(Antoni et al., 1986; Mochan et al., 1986; O'Byrne et al., 
1990b). In the present study twofold evidence was obtained 
that IL-Iß enhanced capsaicin-induced hyperaemia in the rat 
hindpaw via secondary media tors released from 
immunocompetent or other cells. 
A first hint of such a mechanism of action came from the 
use of IL-Iß-(163-171), a fragment of human IL-Iß that is 
devoid of intlammatory activity, such as the induction of 
prostagiandin formation, but which retains the 
immunological activity of the parent molecule in activating 
T-Iymphocytes (Antoni et al., 1986). The finding that IL-tß-
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